--NOTICE OF INTENT TO AWARD

The contract involves an increase to an existing purchase order with Regeneration Technologies for the procurement of Allograft Tissue and Bone products, with an additional amount of $75,000, bringing the total contract value to $100,000. The acquisition is conducted under FAR Part 6.302-1, indicating a justification for other than full and open competition. All products provided under this contract must be FDA approved to ensure safety and compliance with regulatory standards. The allograft tissue and bone products are selected to specifically meet the medical needs and requirements of patients as determined by the requesting surgeon. This contract falls under the NAICS code 621991, which relates to health care practitioner offices, reflecting its focus on medical supplies. The contracting office managing this purchase is the MEDCOM Western Regional Contracting Office located in Tacoma, Washington. Although detailed agency and location information is not specified, the contract’s intent was publicly posted in December 2008. The contract emphasizes the importance of meeting patient-specific medical needs and complies with federal acquisition regulations governing the procurement process.